Newron Pharmaceuticals SpA
SIX:NWRN
Wall Street
Price Targets
NWRN Price Targets Summary
Newron Pharmaceuticals SpA
According to Wall Street analysts, the average 1-year price target for
NWRN
is 47.94 CHF
with a low forecast of 25.25 CHF and a high forecast of 76.65 CHF.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is NWRN's stock price target?
Price Target
47.94
CHF
According to Wall Street analysts, the average 1-year price target for
NWRN
is 47.94 CHF
with a low forecast of 25.25 CHF and a high forecast of 76.65 CHF.
What is Newron Pharmaceuticals SpA's Revenue forecast?
Projected CAGR
38%
For the last 14 years the
compound annual growth rate for
Newron Pharmaceuticals SpA's revenue is
37%.
The projected
CAGR
for the next 4 years is
38%.
What is Newron Pharmaceuticals SpA's Operating Income forecast?
Projected CAGR
55%
The
compound annual growth rate
of Newron Pharmaceuticals SpA's operating income for the next 4 years is
55%.
What is Newron Pharmaceuticals SpA's Net Income forecast?
Projected CAGR
57%
The
compound annual growth rate
of Newron Pharmaceuticals SpA's net income for the next 4 years is
57%.
